OPC-14523
From EverybodyWiki Bios & Wiki
| File:OPC-14523.svg | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
| Chemical and physical data | |
| Formula | C23H28ClN3O2 |
| Molar mass | 413.95 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
OPC-14523 is an investigational antidepressant drug developed by Otsuka Pharmaceutical. Its mode of action is mediated by combined sigma receptor agonism and 5-HT1A receptor agonism. It is based on the structure of mCPP and the synthesis shares the same precursor as was used in the synthesis of cloperidone.
Synthesis:[1] Pharmacology:[2][3][4][5]
References
- ↑ Oshiro, Y., Sakurai, Y., Sato, S., Kurahashi, N., Tanaka, T., Kikuchi, T., Tottori, K., Uwahodo, Y., Miwa, T., Nishi, T. (1 January 2000). "3,4-Dihydro-2(1 H )-quinolinone as a Novel Antidepressant Drug: Synthesis and Pharmacology of 1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1 H )-quinolinone and Its Derivatives". Journal of Medicinal Chemistry. 43 (2): 177–189. doi:10.1021/jm980333v. PMID 10649973.
- ↑ Tottori, K., Miwa, T., Uwahodo, Y., Yamada, S., Nakai, M., Oshiro, Y., Kikuchi, T., Altar, C. A. (December 2001). "Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523". Neuropharmacology. 41 (8): 976–988. doi:10.1016/S0028-3908(01)00147-2. PMID 11747902.
- ↑ Bermack, J. E., Haddjeri, N., Debonnel, G. (August 2004). "Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1a Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus". The Journal of Pharmacology and Experimental Therapeutics. 310 (2): 578–583. doi:10.1124/jpet.104.066472. PMID 15044555.
- ↑ Jordan, S., Chen, R., Koprivica, V., Hamilton, R., Whitehead, R. E., Tottori, K., Kikuchi, T. (July 2005). "In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors". European Journal of Pharmacology. 517 (3): 165–173. doi:10.1016/j.ejphar.2005.05.035. PMID 15985260.
- ↑ Bermack, J. E., Debonnel, G. (January 2007). "Effects of OPC-14523, a combined sigma and 5-HT 1a ligand, on pre- and post-synaptic 5-HT 1a receptors". Journal of Psychopharmacology. 21 (1): 85–92. doi:10.1177/0269881106063996. PMID 16533864.
See also
Template:Sigma receptor modulators
This article "OPC-14523" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:OPC-14523. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
